Reviva Pharmaceuticals Holdings Stock Price on December 20, 2024

RVPH Stock  USD 1.75  0.11  6.71%   
Below is the normalized historical share price chart for Reviva Pharmaceuticals Holdings extending back to October 18, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Reviva Pharmaceuticals stands at 1.75, as last reported on the 25th of December, with the highest price reaching 1.77 and the lowest price hitting 1.54 during the day.
IPO Date
18th of October 2018
200 Day MA
1.7039
50 Day MA
1.3718
Beta
(0.06)
 
Covid
If you're considering investing in Reviva Stock, it is important to understand the factors that can impact its price. Reviva Pharmaceuticals appears to be very risky, given 3 months investment horizon. Reviva Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of 0.0937, which implies the firm had a 0.0937% return per unit of risk over the last 3 months. By analyzing Reviva Pharmaceuticals' technical indicators, you can evaluate if the expected return of 0.97% is justified by implied risk. Please evaluate Reviva Pharmaceuticals' Coefficient Of Variation of 968.56, semi deviation of 8.69, and Risk Adjusted Performance of 0.0918 to confirm if our risk estimates are consistent with your expectations.
  
Reviva Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0937

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsRVPH
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 10.4
  actual daily
92
92% of assets are less volatile

Expected Return

 0.97
  actual daily
19
81% of assets have higher returns

Risk-Adjusted Return

 0.09
  actual daily
7
93% of assets perform better
Based on monthly moving average Reviva Pharmaceuticals is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Reviva Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book
8.3482
Book Value
0.205
Enterprise Value
70.9 M
Enterprise Value Ebitda
(6.00)
Shares Float
26.7 M

Reviva Pharmaceuticals Valuation on December 20, 2024

It is possible to determine the worth of Reviva Pharmaceuticals on a given historical date. On December 20, 2024 Reviva was worth 1.5 at the beginning of the trading date compared to the closed value of 1.34. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Reviva Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Reviva Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Reviva Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Reviva Pharmaceuticals' related companies.
 Open High Low Close Volume
  1.46    1.57    1.44    1.50    2,475,960  
12/20/2024
  1.50    1.51    1.23    1.34    4,481,569  
  1.37    1.64    1.25    1.64    5,974,739  
Backtest Reviva Pharmaceuticals  |  Reviva Pharmaceuticals History  |  Reviva Pharmaceuticals Valuation   PreviousNext  
Open Value
1.5
1.34
Closing Value
32.69
Upside

Reviva Pharmaceuticals Trading Date Momentum on December 20, 2024

On December 23 2024 Reviva Pharmaceuticals Holdings was traded for  1.64  at the closing time. The top price for the day was 1.64  and the lowest listed price was  1.25 . The trading volume for the day was 6 M. The trading history from December 23, 2024 was a factor to the next trading day price growth. The trading delta at closing time against the next closing price was 22.39% . The trading delta at closing time against the current closing price is 26.87% .

Reviva Pharmaceuticals Fundamentals Correlations and Trends

By evaluating Reviva Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Reviva Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Reviva financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Reviva Pharmaceuticals Stock history

Reviva Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Reviva is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Reviva Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Reviva Pharmaceuticals stock prices may prove useful in developing a viable investing in Reviva Pharmaceuticals
Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. It is also developing RP1208 that is in pre-clinical development studies for the treatment of depression and obesity. Reviva Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 5 people.

Reviva Pharmaceuticals Stock Technical Analysis

Reviva Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Reviva Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Reviva Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Reviva Pharmaceuticals Period Price Range

Low
December 25, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Reviva Pharmaceuticals Holdings cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Reviva Pharmaceuticals December 25, 2024 Market Strength

Market strength indicators help investors to evaluate how Reviva Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Reviva Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Reviva Pharmaceuticals stock market strength indicators, traders can identify Reviva Pharmaceuticals Holdings entry and exit signals to maximize returns

Reviva Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Reviva Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Reviva Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Reviva to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Reviva Stock analysis

When running Reviva Pharmaceuticals' price analysis, check to measure Reviva Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reviva Pharmaceuticals is operating at the current time. Most of Reviva Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Reviva Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reviva Pharmaceuticals' price. Additionally, you may evaluate how the addition of Reviva Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Commodity Directory
Find actively traded commodities issued by global exchanges
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine